Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Tosoni

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034Martin J van den Bent, Alba A Brandes, Roy Rampling, et al.
World Neurosurgery|January 17, 2018
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Alicia Tosoni, Santino Minichillo, et al.
Journal of Neuro-Oncology|March 8, 2024
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective studyVincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, et al.
Neuro-Oncology Practice|June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034Martin J van den Bent, Alba A Brandes, Roy Rampling, et al.
World Neurosurgery|January 17, 2018
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Alicia Tosoni, Santino Minichillo, et al.
Journal of Neuro-Oncology|March 8, 2024
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective studyVincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, et al.
Neuro-Oncology Practice|June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Pageof 11